Trademark: 88294201
Word
G
Status Date
Tuesday, January 9, 2024
Registration Number
7265524
Registration Date
Tuesday, January 9, 2024
Filing Date
Friday, February 8, 2019
Published for Opposition
Tuesday, October 24, 2023
41 Providing online non-downloadable audio and video recordings containing information in the field of medical testing services, namely, genetic testing and genetic screening over a global computer network
35 Advertising the goods and services of others focused on the application of personal genetic information for pain management, mental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain management, mental health and other comorbid conditions, and marketing services, namely, marketing consultancy for businesses in the field of personal genetic information for pain management, mental health and other comorbid conditions, all the foregoing not including veterinary or plant applications
44 Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing services, namely, personalized medical tests based on the assessment, development and application of human genomic discoveries in the medical industry; online medical testing services, namely, genetic testing and genetic screening; Medical information services, namely, providing personalized information online in the field of genetic testing for medical purposes; medical information services, namely, reporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, personal genetic information for pain management, mental health and other comorbid conditions and for understanding individual responses to medication, all the foregoing not including veterinary or plant applications; medical information services, namely, analyzing pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications; medical information services, namely, preparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, analyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications
42 Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatments, pharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing services, namely, pharmacogenetic tests, gene sequencing-based tests and genotyping based on the assessment, development and application of human genomic discoveries in the pharmaceutical, informatics and human clinical diagnostic industries, all the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing services, namely, platform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain management, mental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing services, namely, providing genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal
The mark consists of a stylized, rounded lower case "G" having a tilted teardrop-shaped upper portion and floating, curved lower portion.
Color is not claimed as a feature of the mark.
Jan 9, 2024
Notice Of Registration Confirmation Emailed
Jan 9, 2024
Registered-Principal Register
Oct 24, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2023
Published For Opposition
Oct 4, 2023
Notification Of Notice Of Publication E-Mailed
Sep 18, 2023
Electronic Record Review Complete
Sep 15, 2023
On Hold - Electronic Record Review Required
Sep 8, 2023
Approved For Pub - Principal Register
Sep 7, 2023
Teas/Email Correspondence Entered
Sep 6, 2023
Correspondence Received In Law Office
Sep 6, 2023
Teas Response To Office Action Received
Jun 6, 2023
Notification Of Priority Action E-Mailed
Jun 6, 2023
Priority Action E-Mailed
Jun 6, 2023
Priority Action Written
Feb 15, 2023
Teas/Email Correspondence Entered
Feb 15, 2023
Correspondence Received In Law Office
Feb 14, 2023
Assigned To Lie
Feb 6, 2023
Teas Response To Suspension Inquiry Received
Aug 6, 2022
Notification Of Inquiry As To Suspension E-Mailed
Aug 6, 2022
Inquiry To Suspension E-Mailed
Aug 6, 2022
Suspension Inquiry Written
Jul 7, 2022
Suspension Checked - To Attorney For Action
Mar 7, 2022
Assigned To Examiner
Dec 16, 2021
Notification Of Letter Of Suspension E-Mailed
Dec 16, 2021
Letter Of Suspension E-Mailed
Dec 16, 2021
Suspension Letter Written
Jun 10, 2021
Notification Of Letter Of Suspension E-Mailed
Jun 10, 2021
Letter Of Suspension E-Mailed
Jun 10, 2021
Suspension Letter Written
Dec 10, 2020
Notification Of Letter Of Suspension E-Mailed
Dec 10, 2020
Letter Of Suspension E-Mailed
Dec 10, 2020
Suspension Letter Written
Dec 10, 2020
Teas/Email Correspondence Entered
Dec 10, 2020
Correspondence Received In Law Office
Dec 2, 2020
Assigned To Lie
Nov 2, 2020
Teas Response To Suspension Inquiry Received
May 1, 2020
Notification Of Inquiry As To Suspension E-Mailed
May 1, 2020
Inquiry To Suspension E-Mailed
May 1, 2020
Suspension Inquiry Written
Nov 1, 2019
Notification Of Letter Of Suspension E-Mailed
Nov 1, 2019
Letter Of Suspension E-Mailed
Nov 1, 2019
Suspension Letter Written
Oct 28, 2019
Teas/Email Correspondence Entered
Oct 28, 2019
Correspondence Received In Law Office
Oct 23, 2019
Assigned To Lie
Oct 17, 2019
Teas Response To Office Action Received
Sep 24, 2019
Notification Of Examiner's Amendment/Priority Action E-Mailed
Sep 24, 2019
Examiner's Amendment/Priority Action E-Mailed
Sep 24, 2019
Combined Examiner's Amendment/Priority Action Automatic Entry
Sep 24, 2019
Examiners Amendment And/Or Priority Action - Completed
Aug 3, 2019
Teas/Email Correspondence Entered
Aug 2, 2019
Correspondence Received In Law Office
Aug 2, 2019
Teas Response To Office Action Received
Mar 25, 2019
Notification Of Non-Final Action E-Mailed
Mar 25, 2019
Non-Final Action E-Mailed
Mar 25, 2019
Non-Final Action Written
Mar 25, 2019
Assigned To Examiner
Mar 21, 2019
Notice Of Design Search Code E-Mailed
Mar 2, 2019
New Application Office Supplied Data Entered
Feb 12, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
